Navigation Links
Transplant Head Honcho forced to dismount

The Abdominal Transplant Program, beset with administrative problems, experienced another upheaval. In a recent statement, The UCSD communicated its decision to relieve // Dr. Hart, the Director of the program for liver and kidney transplants, of his administrative responsibilities. Notwithstanding, Dr Hart will still continue as a full-time surgeon and member of the University's transplant team.

The UC San Diego, disappointed with the manner in which Dr Marquis Hart had conducted the UC Irvine’s Liver program, perceived to have misled organ officials, instigated his exit. Dr Marquis Hart had been offering part time services to the UCI since 2002 till the fall of 2005. During his tenure, The UCI liver program suffered huge setbacks prompting its closure.

Federal officials said that though the UCI was given 122 livers between 2004 and 2005, only 12 transplantations had occurred, a record low for any such program in the state. The UCI also did not have its own team of surgeons and therefore had to avail the services of Marquis and another UCSD surgeon. Further, Medicare also decided to cancel the payment for UCI’s Liver transplants.

Dr Hart was also part of a contract that allowed him to be a consultant surgeon for the UCI. The financial contract, according to Dr Thomas MacAfee, was between the UC Irvine and The UCSD Department of Surgery, and confirmed that the UCSD was not in the eye of any mischief or allegations. In the UCSD statement, the Chief Executive Officer, Richard Liekweg has reiterated that this is not a slur on the Doctor’s skill and commitment to his work. Infact, Dr Hart is regarded as an outstanding surgeon, deeply committed to his patients.

'"/>




Page: 1

Related medicine news :

1. Stem Cell Transplants May Be Effective For MS Patients
2. Drugs Deter Heart Disease for Transplant Patients
3. Better Drug for Heart Transplant
4. Kidney Failure after Non-Kidney Transplants
5. Measles Risk in Transplant Patients
6. Transplants Help Liver Cancer Patients
7. Steroid-Free Liver Transplants
8. Pancreas Transplant for Diabetics
9. Reducing The Risk Of Fractures After a Heart Transplant
10. A Urine Test Could Predict Rejection In Transplant Patients
11. Thawed Ovarian Transplant
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... January 24, 2017 , ... The health insurance industry is ... (AEP) and the Open Enrollment Period (OEP). 2016 was no exception. If anything, ... witnessing higher deductibles, rising premiums, and few choices with their insurance, which is ...
(Date:1/24/2017)... ... , ... The Cruise Web Inc. was recognized today as Northeast ... Annual MSC True Partnerships’ Awards. , The 2016 MSC True Partnerships Awards are ... on overall business growth in revenue and guests and continuous partnership support and innovative ...
(Date:1/24/2017)... ... January 24, 2017 , ... OMI Industries, a worldwide leader ... distribution partnership with Byers Scientific & Manufacturing , a leading designer, engineer ... agreement, OMI Industries formulated a special version of Ecosorb® for Byers Scientific & ...
(Date:1/24/2017)... Hill, N.C. (PRWEB) , ... January 24, 2017 ... ... Trump Administration is the focus of a new report from the Frank ... Kenan-Flagler Business School. , Influential business leaders, academics and policy makers identified concrete ...
(Date:1/24/2017)... ... January 24, 2017 , ... Date aired: January 23, 2017 ... the nation’s foremost water advocate and host of the nationally syndicated The Sharon ... America, once again welcomed one of her favorite guests and colleagues, Dr. Gerald ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Md. , Jan. 24, 2017   Intrexon Corporation ... engineering and industrialization of biology to improve the quality of ... has entered into a definitive agreement to acquire GenVec, ... and pioneer in the development of AdenoVerse™ gene delivery technology.  ... GenVec,s expertise in adenoviral vectors and cGMP drug product manufacturing ...
(Date:1/24/2017)... , Jan. 24, 2017   QR ... biopharmaceutical company developing novel therapies for the treatment ... announced the appointment of four world-class key opinion ... new appointments join QR Pharma,s previous roster of ... and direction to support the development of the ...
(Date:1/24/2017)... Research and Markets has announced the addition of the "Optogenetics ... report to their offering. ... Global Optogenetics Market is poised to grow at ... approximately $76.24 million by 2025. Some of the prominent ... using optogentic techniques for neurosciences, quick growth ultrafast laser tools technology, ...
Breaking Medicine Technology: